Dicoumarol attenuates NLRP3 inflammasome activation to inhibit inflammation and fibrosis in knee osteoarthritis

In conclusion, the present findings demonstrated that dicoumarol could impede the progression of KOA by inhibiting NLRP3 activation, providing a potential treatment strategy for KOA.PMID:38639180 | DOI:10.3892/mmr.2024.13224
Source: Molecular Medicine Reports - Category: Molecular Biology Authors: Source Type: research